Can a VR treadmill help Parkinson's patients walk better?
NCT ID NCT05703217
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a virtual reality treadmill (C-Mill) could improve walking and balance in people with Parkinson's disease better than standard physical therapy. Twenty patients aged 60-80 with mild to moderate Parkinson's were randomly assigned to either VR treadmill rehab or classical therapy. Researchers measured changes in gait, balance, and quality of life over 21 sessions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- C-Mill virtual reality treadmill rehabilitation
- What this could lead to
- If it works, this could offer a more engaging and effective way to improve walking and balance for people with Parkinson's disease.
- What could go wrong
- This is a very small, completed study with only 20 participants, so results may not apply to everyone. The virtual reality approach may not be better than standard therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Jun 2022
- Finished
-
Jun 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Inclusion criteria: * Women and men * 60-80 years old Those who have been diagnosed with Parkinson's disease and are using regular drug therapy * Hoehn Yahr Stage: 2-3-4 Hoehn-Yahr Staging: Stage 0- No signs of disease. Stage 1- Unilateral disease. Stage 1.5- Unilateral plus axial involvement. Stage 2- Bilateral disease, no balance disorder. Stage 2.5- Mild bilateral disease recovering in the pull test. Stage 3 - Mild to moderate bilateral disease and some postural instability, physically independent. Stage 4 - Severe disability, able to stand and walk unaided. Stage 5 - unassisted wheelchair or bed dependent. Can be mobilized without support or with minimal support Exclusion Criteria: Criteria for exclusion of volunteers from the study: * psychiatric illness, dementia * advanced vision and hearing problems * diseases that limit walking and movement: joint disease (knee, hip joint diseases), advanced spinal stenosis, lumbar discopathy, hemiplegia * heart failure and respiratory failure
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Parkinson disease are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Romatem Romatem Physical Therapy and Rehabilitation Hospitals Bursa Hospitals Bursa Hospital
Bursa, 16030, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Individualized 130 hz subthalamic temporal interference stimulation versus medication for motor symptoms in parkinson disease
- Home-Based prehabilitation using wireless wearable mobile monitoring devices for elderly patients with Non-Small cell lung cancer
- Parkinson's improvement activated by hula understanding (PAHU) - part 2
- Half a million people join quest to decode Parkinson's risk
- Can a diabetes drug slow Parkinson's? a trial puts it to the test
- Horseback therapy may help Parkinson's patients move better